Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
Not yet recruiting · NCT07586865 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, anterolateral myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 2 | 2026-05-14 | NCT07586865 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Northland Biotech. Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuwai Hospital Chinese Academy of Medical Sciences (CAMS) | Beijing | China | 2 |